SCROLL DOWN

In 2024, an estimated 10.7 million people fell ill with tuberculosis (TB) worldwide and 1.23 millions died from TB.1

Innovative Research & Development

Otsuka searches for innovative solutions to address gaps in TB treatment.

Responsible Access to Medicines

Otsuka’s working on widening access to a multidrug-resistant TB (MDR-TB) medicine while ensuring antimicrobial stewardship.

Collaborations

Collaboration is essential in the fight against TB.

Curbing Drug Resistance

Otsuka’s antimicrobial resistance task force works to curb resistance to antibiotics used in MDR-TB treatment.

References

1. Global tuberculosis report 2025. Geneva: World Health Organization; 2025. Licence: CC BY-NC-SA 3.0 IGO.

Information current as of March 2026
Reference ONP-DEL-2300007 v4.0

Discover Otsuka